CMS considers pilot plan for covering weight loss drugs — reportnews2025-08-01T19:02:02+00:00August 1st, 2025|Endpoints News|
Lilly to sell New Jersey facility as it nears picks for new US sitesnews2025-08-01T17:30:48+00:00August 1st, 2025|Endpoints News|
Moderna gets UK appeals court win in Covid patent battle with Pfizer, BioNTechnews2025-08-01T17:18:46+00:00August 1st, 2025|Endpoints News|
FDA requires opioid label updates to highlight long-term risksnews2025-08-01T16:19:30+00:00August 1st, 2025|Endpoints News|
Regeneron CEO speaks on Trump’s ‘most favored nation’ pricingnews2025-08-01T15:29:13+00:00August 1st, 2025|Endpoints News|
Analysts wary of Moderna’s CMV fate after new endpoints addednews2025-08-01T15:14:55+00:00August 1st, 2025|Endpoints News|
Sanofi buys China rights to Arrowhead’s lipid drug for $130M upfrontnews2025-08-01T14:47:28+00:00August 1st, 2025|Endpoints News|
United Therapeutics’ $1B share buyback; Layoffs at a Roivant subsidiarynews2025-08-01T13:49:10+00:00August 1st, 2025|Endpoints News|
Allogene says lymphodepletion drug caused patient death, changes CAR-T study designnews2025-08-01T12:30:30+00:00August 1st, 2025|Endpoints News|
Regeneron gets another CRL, predicts delayed August PDUFA for Eylea HDnews2025-08-01T11:37:56+00:00August 1st, 2025|Endpoints News|
